BioViva's CEO, Liz Parrish, is serving as the first human test subject for 2 therapies designed to reverse aging. She...

BioViva's CEO, Liz Parrish, is serving as the first human test subject for 2 therapies designed to reverse aging. She is receiving 2 kinds of injections, administered outside the : a myostatin inhibitor, which may prevent age-associated muscle loss; & a telomerase gene therapy, which may lengthen telomeres, segments of DNA at the ends of chromosomes whose shortening is associated with aging & degenerative disease.

Bình luận

Older

Loading